ImmunoMedics Should Be On Your Radar Before Phase 2 Breast Cancer Data Update [Seeking Alpha]
IMMUNOMEDICS (IMMU)
Last immunomedics earnings: 2/27 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
immunomedics.com/2017/immunomedics-announces-presentations-investor-event-2017-san-antonio-breast-cancer-symposium
Company Research
Source: Seeking Alpha
ImmunoMedics Should Be On Your Radar Before Phase 2 Breast Cancer Data UpdateSummaryUpdated phase 2 Metastatic Triple-Negative Breast cancer data should act as a major catalyst for the stock.ImmunoMedics is nearing the first quarter of 2018 when it will file for its Biologics License Application to the FDA for accelerated approval of IMMU-132.Early phase 2 data in Metastatic Triple-Negative Breast cancer patients already achieved over the threshold set by the FDA for accelerated approval for this patient population.Should ImmunoMedics obtain accelerated approval in 2018, it is likely that it will have to raise more capital to launch IMMU-132 on the market.A late-stage study known as ASCENT has already been initiated, and will act as a post-marketing study for the FDA. The outcome will determine if IMMU-132 can continue to remain on the market.
Show less
Read more
Impact Snapshot
Event Time:
IMMU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMMU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMU alerts
High impacting IMMUNOMEDICS news events
Weekly update
A roundup of the hottest topics